EAT is up +49.38%% since April’24 pick View All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 501 days ( -15.65 % )
Last Price $25.76 0 %
High/ Low $25.76 - $25.76 0%
Chg 7 Days N/A $25.76 $25.76
Chg 30 Days N/A $25.76 $25.76
Chg 12 mos 21.20 % $21.25 $25.76
Trend - 3 mos 5.17 % Width: 8.34 %
Trend - 12 mos 36.37 % Width: 25.03 %
Pred. range - 3 mos $25.04 - $27.13 -2.77 % - 5.34 %
Pred. range - 12 mos $32.65 - $40.83 26.78 % - 58.51 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Buy May 02, 2024 - 37 days
Short/Long MA avg 3 mos Buy May 08, 2024 - 33 days
Short MA avg 12 mos Buy May 02, 2024 - 37 days
Long MA avg 12 mos Buy May 02, 2024 - 37 days
Short/Long MA avg 12 mos Buy May 30, 2024 - 18 days
Pivot Short Sell Jun 21, 2024 - 3 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Swedish Orphan Biovitrum AB (publ)

Swedish Orphan Biovitrum AB (publ) Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases in Europe, North America, and internationally. It offers Alprolix for haemophilia B; Doptelet treatment of thrombocytopenia; Elocta for haemophilia A; Gamifant for hemophagocytic lymphohistiocytosis(HLH); Kineret for cryopyrin ... BIOVF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT